Study on novel neutron irradiation without beam shaping assembly in Boron Neutron Capture Therapy
Metadatos
Mostrar el registro completo del ítemEditorial
Springer Nature
Materia
BNCT Neutron production IAEA quality factors
Fecha
2024-09-28Referencia bibliográfica
Verdera Garau, A. & Praena Rodríguez, A.J. Sci Rep 14, 22434 (2024). [https://doi.org/10.1038/s41598-024-73458-w]
Patrocinador
Project PID2020.117969RB.I00 funded by MICIU/AEI /10.13039/5011000110 33; Spanish projects Junta de Andalucía (FEDER Andalucia 2014-2020) P20-00665 and B-FQM-156-UGR20Resumen
Boron Neutron Capture Therapy (BNCT) is performed using high-intensity neutron sources; however,
the energy of the primary neutrons is too high for direct patient irradiation. Thus, neutron moderation
is mandatory and is performed using a device known as a Beam Shaping Assembly (BSA). Due to the
differences in flux and energy spectra between neutron sources, each facility needs a dedicated BSA
design, whether it is based on a nuclear reactor or, more recently, on an accelerator. Since moderation
involves the loss of neutrons, typically by a factor of 1000, it is necessary to generate a very high flux
before neutrons pass through the BSA. We propose a novel approach that eliminates the necessity
of a BSA, BSA-free, by generating neutrons suitable in flux and energy for direct patient irradiation
through the 45Sc(p,n)45Ti reaction using near-threshold protons. Our findings demonstrate that all
IAEA quality factors for BNCT can be met with existing proton accelerators. Additionally, figures of
merit studied provide similar results compared to real BNCT facilities. This breakthrough opens up new
avenues in BNCT, among others, the control of the neutron penetration within the human body by
small changing in the proton energy. Also, it is expected simplified accelerator-based facilities in terms
of manufacturing and maintenance and operation. This work is a study based on experimental data
and Monte Carlo simulations. Technical challenges and safety are addressed in Discussion section. This
novel proposal is under evaluation as patent.